Placeholder Banner

BIO Launches “Innovation Saves” Ad to Highlight Value of Biopharmaceutical Innovation

September 6, 2016

Washington, D.C. (September 6, 2016) – The Biotechnology Innovation Organization (BIO) today launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money.  The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which seeks to highlight the value of biopharmaceutical innovation, the importance of protecting the ecosystem that makes new cures and treatments possible and ensuring that patients have access to these important innovations.

“The cheapest way to treat a disease is to cure it,” said BIO President & CEO Jim Greenwood. “We all know people whose lives were changed or saved thanks to biopharmaceutical innovation, but what many don’t know is the impact these breakthroughs have on society.  BIO is committed to not only defending the value of these lifesaving medicines to patients, but also showcasing the value they bring to the broader healthcare system.”

“These medicines can prevent or curb numerous hospital stays and doctor visits,” added Greenwood. “That’s why biopharmaceutical innovation not only helps to save lives, but also saves money.”

The ads highlight real stories from patients and their loved ones. These ads will show not only how biopharmaceutical innovations helped save their lives, but are also saving money and providing value to the broader healthcare system. They will run across the country over the next several weeks.

Innovation Saves can be viewed HERE. For more information on the advertisement or BIO’s Value Campaign, please visit: http://InnovationSaves.Life.

 

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


Upcoming BIO Events 

BIO Animal Biotech Summit

September 21-23, 2016

Bethesda, MD

BIO IP & Diagnostics Symposium

September 29, 2016

Alexandria, VA

BIO Investor Forum

October 18-19, 2016

San Francisco, CA

BIO Latin America Conference

October 26-28, 2016
Grand Hyatt São Paulo, Brazil

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…